Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR -mutated non-small cell lung cancer treated with erlotinib
2016 · Lung Cancer · 111 citations
https://doi.org/10.1016/j.lungcan.2016.08.001
C
Christina Demuth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
936
Citations
16
h-index
23
i10-index
Christina Demuth is an academic researcher from Aarhus University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 16, co-authored 61 publications.
ORCID: 0000-0003-0237-9758Papers by this author
worksUnraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohort
2023 · Annals of Oncology · 68 citations
https://doi.org/10.1016/j.annonc.2023.11.009
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients
2017 · British Journal of Cancer · 55 citations
https://doi.org/10.1038/bjc.2017.215
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients
2016 · Translational Oncology · 13 citations
https://doi.org/10.1016/j.tranon.2016.09.003
DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection
2023 · Genome biology · 11 citations
https://doi.org/10.1186/s13059-023-02920-1
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
2024 · British Journal of Cancer · 7 citations
https://doi.org/10.1038/s41416-024-02867-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat